Delivery Order SPE2DB22D1017-SPE2DB24FF1YF
Award Date 1/26/24
Potential Completion Date 1/29/24
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a Delivery Order valued at $1,442.63, is for the supply of Naftifine HCL 1% Cream, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp, through its Corporate...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $4,737.94 for the supply of NAFTIFINE HCL 1% CREAM 60GM. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract type is Firm Fixed Price, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $887.51 delivery order to Amerisourcebergen Drug Corporation for NAFTIFINE HCL 1% cream in 60gm quantities. The firm fixed price order calls for delivery to a location in Conshohocken, Pennsylvania by August 15, 2023 to support DLA programs. Amerisourcebergen will serve as the prime contractor to fulfill the requirements on behalf of the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, to provide...
- The Defense Logistics Agency awarded a delivery order valued at $3,266.05 to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram units. This is a competitively awarded, non-set-aside contract with firm fixed pricing and a completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single task issued against a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram quantities, with a ceiling value of $2,146.02. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 12, 2025. This delivery order is a child contract under...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order valued at $1,385.12 for the supply of 4565752999 - Naftifine HCL 2% Cream 45GM. The contract was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued at up to $999,999,999 and $750,000 respectively,...
- This federal contract award is for the delivery of Naftifine HCL 2% Cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,024.72 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,182.95 of Naftifine HCL 1% Cream (60GM) with an ultimate completion date of October 29, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued...
- This federal contract award, with the ID SPE2DB22D1017|SPE2DB25FF1HQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,003.36, is for the delivery of 4566719352 - NAFTIFINE HCL 2% GEL 60GM. This is a firm fixed-price delivery order contract, with a completion date of December 16, 2024. The contract does not have a set-aside designation, indicating open competition....
- This is a Delivery Order (DO) contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NAFTIFINE HCL 2% CREAM 45GM. The $2,163.33 Firm Fixed Price contract has a completion date of September 22, 2021. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF1YFDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,036.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NAFTIFINE HCL 1% CREAM 60GM. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Generated 4/26/24, 11:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/26/24 |